| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23.4M | +7.7% | +24.3% |
| Cost of Revenue | $15.8M | -0.9% | +14.1% |
| Gross Profit | $7.6M | +31.7% | +52.5% |
| R&D Expense | $561K | +26.4% | +28.0% |
| SG&A Expense | $1.5M | -77.1% | +26.0% |
| Operating Income | $5.1M | +318.0% | +73.0% |
| Pre-tax Income | $7.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.9M | -13.8% | -77.6% |
| Short-term Investments | $29.1M | +57.1% | +312.5% |
| Accounts Receivable | $21.6M | -2.6% | +6.3% |
| Inventory | $23.9M | -2.2% | +9.2% |
| Current Assets | $99.0M | +4.6% | -1.2% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.8M | — | — |
| Capital Expenditures | $265K | — | — |
| Investing Cash Flow | -$681K | — | — |
| Financing Cash Flow | -$12.3M | — | — |
| Free Cash Flow | $7.5M | — | — |
| +492.8% |
| +966.9% |
| Income Tax | $920K | +8.4% | +167.3% |
| Net Income | $5.7M | +277.7% | +937.6% |
| EPS (Basic) | $0.33 | +265.0% | +760.0% |
| EPS (Diluted) | $0.33 | +265.0% | +760.0% |
| $123.4M |
| -0.1% |
| -3.2% |
| Current Liabilities | $51.2M | -9.0% | -14.3% |
| Total Liabilities | $53.6M | -11.2% | -19.1% |
| Stockholders' Equity | $75.4M | +9.0% | +32.0% |